Ativan: Clinical Trials

37 trials of Ativan, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

24 completed, 4 terminated, 3 unknown, 2 active not recruiting. 11 Phase 4, 8 Not applicable, 8 Phase 2, 6 Phase 3, 5 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 411Completed 6, Recruiting 2, Unknown 2, Withdrawn 1
Not applicable8Completed 7, Terminated 1
Phase 28Completed 5, Active not recruiting 1, Terminated 1, Withdrawn 1
Phase 36Completed 3, Active not recruiting 1, Terminated 1, Unknown 1
Phase 15Completed 4, Withdrawn 1
Early Phase 12Active not recruiting 1, Terminated 1

Follow Ativan: new trials by email Literature Review of Ativan trials Research Report on Ativan

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Computational Assessment of GABA Receptor Modulation in PTSD
Lorazepam 1 mg tablet, Placebo tablet - Stress Disorders, Post-Traumatic
Phase 4RecruitingVA Office of Research and Development1502025-07-012026-06-16
Intranasal Dexmedetomidine vs. Standard of Care for Emergency Department (ED) Procedural Sedation in the Older Adult
Dexmedetomidine, Lorazepam, Haloperidol - Altered Mental Status
Phase 3UnknownState University of New York - Upstate Medical University602024-06-012024-04-22
Processes and Circuitry Underlying Threat Sensitivity as a Treatment Target for Co-morbid Anxiety and Depression
Lorazepam, Placebo - Depression, Anxiety, Fear
Phase 4RecruitingLaureate Institute for Brain Research, Inc.1652023-11-082025-10-31
Evaluating Sublingual Dexmedetomidine For Moderate To Severe Agitation In Inpatients With Schizophrenia Or Bipolar Disorder
Dexmedetomidine, Lorazepam 2 MG/ML - Schizophrenia Agitation, Schizo Affective Disorder
Phase 4UnknownTemple University322023-07-012023-10-23
Therapies for Down Syndrome Regression Disorder
Lorazepam, Intravenous immunoglobulin (IVIG), Tofacitinib - Down Syndrome, Regression
Phase 2CompletedUniversity of Colorado, Denver662023-06-292026-09-03
Pharmacological Mechanisms of Low-intensity Focused Ultrasound for Motor Cortex Neuroplasticity
Carbamazepine, Lorazepam, Dextromethorphan - Low Intensity Focussed Ultrasound
Early Phase 1Active not recruitingUniversity Health Network, Toronto202021-05-252025-08-03
Multimodal Analgesia Effect on Post Surgical Patient
Neurontin, Dilaudid Injectable Product, Marcaine Injectable Product - Obesity, Morbid, Surgery
Phase 4CompletedUniversity of California, Davis602021-01-202026-09-14
Phenobarbital vs Ativan for Alcohol Withdrawal in the Intensive Care Unit
Phenobarbital, Lorazepam - Alcohol Withdrawal, Alcohol Withdrawal Delirium
Phase 4UnknownOSF Healthcare System1422020-07-062020-10-08
Multi-modal Assessment of Gamma-aminobutyric Acid (GABA) Function in Psychosis
Placebo and fMRI, Lorazepam and fMRI - Schizophrenia, Bipolar Disorder
Phase 4CompletedUniversity of Michigan1432020-01-162026-06-17
Haloperidol and Lorazepam in Controlling Symptoms of Persistent Agitated Delirium in Patients With Advanced Cancer Undergoing Palliative Care
Haloperidol, Lorazepam, Placebo - Delirium, Locally Advanced Malignant Neoplasm
Phase 2 / Phase 3Active not recruitingM.D. Anderson Cancer Center1102019-07-172026-06-15
Alcohol Withdrawal Syndrome Treated With Adjunctive Phenobarbital or Ketamine
Ketamine, Phenobarbital, Lorazepam - Alcohol Withdrawal Syndrome
Phase 4WithdrawnSanta Barbara Cottage Hospital2019-04-122019-09-19
Benzodiazepines for the Reduction of Distress and Pain During and After Emergency Department Care
Placebos, Lorazepam - Acute Pain
Phase 2TerminatedMaria Pacella12019-01-252020-03-09
Oral Sedation During Cervical Dilator Placement
Oxycodone and Lorazepam (Active Comparator), Placebo Comparator - Oral Sedation and Cervical Dilator Pain
Phase 4CompletedJohns Hopkins University272017-06-282020-03-30
Indenoisoquinoline LMP744 in Adults With Relapsed Solid Tumors and Lymphomas
LMP744, Ondansetron, Olanzapine - Solid Tumors, Lymphoma
Phase 1CompletedNational Cancer Institute (NCI)362017-02-272024-12-10
A Multi-level Life-span Characterization of Adult-depression and Effects of Medication and Exercise
Venlafaxine XR, Aerobic Exercise, Lorazepam - Depression, Depressive Disorder, Major
Phase 4CompletedKirk Erickson, PhD312015-03-012018-05-23
Clobazam Use in Epilepsia Partialis Continua - Pilot Study
Clobazam, Clonazepam, Lorazepam - Epilepsia Partialis Continua, Kojewnikov's Epilepsy
Phase 3TerminatedThe Cooper Health System72014-07-012018-05-09
The Comparison of Stress Response to Rapid Opioid Detoxification Applying Different Methods of Opioid Antagonism
Naltrexone, Clonidine, Lorazepam - Opiate Addiction
Not applicableCompletedVilnius University602014-05-012015-02-12
Liver Fibrosis in Alpha-1 Antitrypsin Deficiency (Liver AATD)
Abdominal ultrasound, History and physical, Intravenous catheter - Liver Fibrosis, Alpha-1 Antitrypsin Deficiency
CompletedUniversity of Florida1092013-10-012023-08-21
Characterizing and Predicting Drug Effects on Cognition
Lorazepam, Placebo, Topiramate 100mg - Cognitive Deficits
Phase 4CompletedUniversity of Minnesota602013-07-012019-12-17
Catatonia in Nodding Syndrome and Lorazepam Treatment
Lorazepam - Catatonia, Nodding Syndrome
Phase 1CompletedMakerere University162013-03-012015-06-03

Showing 20 of 37. Sign in to see all of them.

Conditions studied

Bipolar Disorder (3)  ·  Psychotic Disorders (3)  ·  Alzheimer Disease (2)  ·  Anxiety Disorders (2)  ·  Catatonia (2)  ·  Depression (2)  ·  Schizophrenia (2)  ·  Status Epilepticus (2)  ·  Acute Pain (1)  ·  Agnosia (1)  ·  Alcohol Withdrawal Delirium (1)  ·  Autoimmune Diseases (1)  ·  Autoimmune Diseases of the Nervous System (1)  ·  Cognition Disorders (1)  ·  Critical Illness (1)

Sponsors

Virginia Commonwealth University (3)  ·  Mayo Clinic (2)  ·  National Cancer Institute (NCI) (2)  ·  AstraZeneca (1)  ·  Columbia University (1)  ·  Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (1)  ·  Johns Hopkins University (1)  ·  Kirk Erickson, PhD (1)  ·  Laureate Institute for Brain Research, Inc. (1)  ·  M.D. Anderson Cancer Center (1)  ·  Makerere University (1)  ·  Maria Pacella (1)  ·  Mclean Hospital (1)  ·  OSF Healthcare System (1)  ·  Orasi Medical, Inc. (1)

Countries

United States (30)  ·  Canada (2)  ·  Brazil (1)  ·  Lithuania (1)  ·  Netherlands (1)

Top investigators

Alice P Chen, M.D. (2)  ·  Angela Christiano, PhD (1)  ·  Angelina Kakooza-Mwesige, MMed (1)  ·  Barbara Jachniewicz, MSN, CRNFA, (1)  ·  Beth L Murphy, MD/PhD (1)  ·  Bhagat Aulakh, MD (1)  ·  Carolyn Sufrin (1)  ·  Concetta Forchetti, MD, PhD (1)  ·  Cynthia M Stonnington, M.D. (1)  ·  Cynthia Stonnington, MD (1)  ·  Daniel H Lowenstein, MD (1)  ·  David Hui (1)  ·  Devon Fletcher (1)  ·  Dirk M Dhossche, MD, PhD (1)  ·  Elise Sannar, MD (1)

Results publications

PMID 16785215, PMID 19573495, PMID 21967361, PMID 22144928, PMID 22335736, PMID 22506949, PMID 22898443, PMID 22950484, PMID 24001080, PMID 24756515, PMID 26710961, PMID 27993298, PMID 28781452, PMID 30138687, PMID 30797651, PMID 32029262, PMID 32297992, PMID 33692709, PMID 33728561, PMID 34238838, PMID 34546899, PMID 34820831, PMID 35971024, PMID 35987977, PMID 36302173, PMID 36448276, PMID 40439882, PMID 40742738

NIH funding

K23AA000222 (1), K23DA014291 (1), R01MH118634 (1), R01MH132565 (1), U01NS056975 (1)